ADIAL PHARMACEUTICALS, INC. (ADIL) Operating cash flow 2017–2025
ADIAL PHARMACEUTICALS, INC. (ADIL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.5MFY2025 · since FY2017: -$494,862 → -$6.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.5M | +6.2% |
| FY2024 | -$6.9M | -1.7% |
| FY2023 | -$6.8M | +39.1% |
| FY2022 | -$11.2M | +6.4% |
| FY2021 | -$11.9M | -56.5% |
| FY2020 | -$7.6M | -20.4% |
| FY2019 | -$6.3M | -153.7% |
| FY2018 | -$2.5M | -404.9% |
| FY2017 | -$494,862 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADIL financial trends
ADIL RevenueADIL Net incomeADIL Net marginADIL Gross profitADIL Gross marginADIL Operating incomeADIL Operating marginADIL Free cash flowADIL Capital expendituresADIL Return on equityADIL Stock buybacksADIL Dividends paidADIL Total assetsADIL Total liabilitiesADIL Shareholders’ equityADIL overview →